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For spinal cord, brain stem and mandible the analysis 
included the maximum dose (in terms of D2%); for parotids, 
salivary glands, esophagus, larynx and thyroid Dmean and a 
number of different dose-volume data in the range V20Gy e 
V50Gy were compared.For comparison of the efficiency of 
IMRT and CDR-VMAT, the MUs and treatment delivery time 
were also recorded and evaluated. 
 
Results: Results are shown in Table. 
 
 
 
Differences were analysed using the paired samples Wilcoxon 
test (significance level 0,05). Although differences were not 
always statistically significant, on the one hand CDR-VMAT 
improved HI and decreased D2% for PTVs, on the other hand 
it showed a reduction in the volume of the OARs receiving 
medium and high doses and medium doses to larynx, thyroid, 
parotid and salivary glands. In respect of some organs, such 
as the esophagus, a larger number of patients enrolled in the 
study would likely have resulted in statistically significant 
differences. Compared with IMRT, CDR-VMAT reduced 
delivery times although MUs were higher. 
 
Conclusion: Our study showed that CDR-VMAT offers an 
additional option of rotational arc radiotherapy for linacs 
without variable dose rate with a lower cost.  
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Purpose or Objective: The aim of this study was to evaluate 
the feasibility of complete-directional-complete block (CDCB) 
technique and to find the optimal restricted angle of helical 
tomtherapy (HT) in planning of locoregional irradiation 
including the internal mammary chain (IMC) in left-sided 
breast cancer. 
 
Material and Methods: Treatment plans were generated for 6 
left-sided breast cancer patients with a planning target 
volume (PTV) included the breast/chest wall, supra-
clavicular, axillary nodes and IMC. In HT plans, complete 
block (CB) and CDCB were designated to spare the contra-
lateral tissues: (1) CB was a rectangular structure with the 
ends connected to 10-cm away from the margin of the PTV 
(2) the directional-blocking area of CDCB was determined by 
the intersection of CB and the beam aperture passed through 
the 0.5 cm margin of IMC. To find the optimal CDCB, the 
angle of 0, 10, 15 and 20 degree of the beam according to 
the geometric center of IMC were used. A prescribed dose of 
50 Gy in 25 fractions was planned for HT plans using CB, 
CDCB 0,10,15,20 and conventional 5-field intensity-
modulated radiotherapy (cIMRT). The dose coverage, 
homogeneity index (HI), conformity index (CI) of the target, 
and the dose volumes of critical structures were compared. 
 
Results: The coverage, HI and CI of PTV in HT-CDCB 
0,10,15,20 were better than those in cIMRT but did not differ 
from HT-CB. The mean V20 Gy of the ipsilateral lung for HT-
CDCB 15 (22.2%±3.1%, p=0.029) and HT-CDCB 20 (22.1%±3.5%, 
p=0.045) were significant reduced compared to cIMRT 
(27.9%±3.4%). With the increasing angle of CDCB, the cardiac 
V30 Gy for HT-CDCB was gradually decreased and 
significantly lower than for cIMRT and HT-CB. Compared with 
cIMRT (24.3 Gy±6.9 Gy), the mean dose of left anterior 
descending coronary artery was effectively reduced 38.6%, 
43.3%, 45.8% and 48.1% in CDCB 0,10,15,20, respectively. 
There was no significant difference in contralateral breast for 
all plans. However, the mean dose of contralateral lung in 
HT-CDCB 20 was 6.1% higher than cIMRT (1.7 versus 1.6 Gy) 
and 14.5% than HT-CDCB 15 
 
Conclusion: CDCB technique is feasible for locoregional 
irradiation including the IMC in left-sided breast cancer 
patients treated with helical tomotherapy. Considering the 
mean dose of the contralateral lung, the optimal angle for 
CDCB could be 15-degree that not only achieved similar PTV 
coverage, homogeneity and dose conformity but also allowed 
better sparing heart and bilateral lungs compared with 
cIMRT. 
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Purpose or Objective: The purpose of the present study was 
to evaluate dosimetric comparision of volumetric modulated 
arc therapy(VMAT) and helical tomotherapy(HT) for patients 
with endometrial cancer. 
 
Material and Methods: Fourteen patients with endometrial 
cancer were retrospectively studied.All whole pelvis(WP) 
patients were treated with 50.4 Gy in 28 fractions..The dose 
distributions for the planning target volume (PTV),organs at 
risk(OARs),monitor unit(MU) and homogeneity index(HI= D2-
D98/Dmedian) were analyzed. 
 
Results: The V93 and D100 of PTV were 99.8% ,99.4% and 
46.3 Gy,48.2 Gy for the VMAT and 
HT,respectively(p:0.004,p:0.003) .The V20 for the bowels 
was 44.5 Gy and 51.1 Gy for the VMAT and HT, 
respectively(p:0.001). The sparing OARs were comparable 
between the VMAT and HT plans. There is a significance 
difference between MU for the VMAT and HT plans and the 
value was given by 645 and 5236 MU(p:0.001) and the 
average homogeneity index was 0.07 and 0.04 
(p:0.002),respectively. 
 
Conclusion: Both HT and VMAT plans yielded with 
homogeneous dose distrubition when sparing of OARs 
effectively. Although some dosimetric parameters have 
shown significant differences statistically but they were 
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small. VMAT is a well suited technique with shorter 
treatment time but HT plans have better HI than VMAT.  
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Purpose or Objective: Dosimetric comparison among 
treatment plans from different RT techniques (photons, 
protons and carbon ions) within a prospective multicentric 
trial aiming at the evaluation of the impact of combined 
treatment modalities on target coverage and OARs sparing for 
sinonasal tumors. 
 
Material and Methods: High risk PTV (HR-PTV), which 
comprised gross disease, and low risk volume (LR-PTV), with 
elective neck, were defined for 5 pts. Four treatment plans 
were generated for each pt: a pure sequential (SEQ) and a 
pure SIB photon plan, a particle sequential plan with protons 
and carbon ion boost (p+C) and a combined plan with photons 
and carbon ion boost (ph+C). Prescription doses (PD) to HR-
PTV were 70 Gy (2 Gy/die) for photon plans and 75 GyE for 
plans with a carbon ion boost (21 GyE in 7 frs). PD to LR-PTV 
were 56 Gy (1.6 Gy/die) for SIB modality and 54 Gy (2 
Gy/die) for sequential plans. Varian Eclipse TPS was used to 
optimize VMAT photon plans with coplanar and non-coplanar 
arcs. Particle plans were calculated using Siemens Syngo TPS 
and IMPT optimization strategy. The highest priority during 
optimization was given to spare neurological structures, 
followed by PTVs coverage and then remaining OARs. A 
dedicated software (VODCA, MSS Medical Software Solution 
GmbH, Switzerland) was used to sum up photon and particle 
plans and to compare DVHs from different approaches. We 
considered different parameters: the most significant for 
PTVs coverage were volume encompassed by 70 Gy isodose 
(V70Gy), conformity index and homogeneity index. As for 
OARs, V10Gy was reported for temporal lobes, brain and 
mean dose (Dmean) for contra-lateral optic nerve, chiasm, 
cord, brainstem, cochleae. Integral dose was recorded to 
evaluate healthy tissue (HT, patient volume minus larger 
PTV). Differences in techniques were analyzed by paired 
Student’s 2-sided t-tests for each dosimetric parameter, 
taking p-value <0.05 as statistically significant. 
 
Results: All plans could be considered clinically acceptable. 
The photon ones showed a better conformality and 
homogeneity for HR-PTV against p+C plans. Although 
minimum dose (as percentage of PD) was higher for photon 
plans, V70Gy was statistically relevant in favor of p+C plans 
vs the other modalities. Despite a higher PD for plans with 
carbon ion boost, a significant advantage on some OARs was 
recorded: Dmean in p+C plans was significantly lower for 
contra-lateral optic nerve, chiasm and cochleae, as it is 
V10Gy for temporal lobes and brain. This finding was 
reinforced by a statistically significant difference in integral 
dose for p+C plans vs the others, but also for ph+C plans vs 
SIB. See averaged DVHs in Fig. 1. 
 
 
 
Conclusion: Although less homogeneous and conformed, 
particle plans allow a higher PD to HR-PTV compared to 
photons. Due to their specific physical characteristics, 
combined particle treatments can potentially better spare 
OARs and HT in terms of intermediate and low doses. 
 
EP-1697  
Evaluating patient dose difference in case of linac transfer 
under treatment 
A. Vasseur
1Centre d'Oncologie et de Radiothérapie du Parc, 
Radiothérapie - Auxerre, Auxerre, France 
1, C. Bertin2, J.Y. Gosselin1, B. Foulon1 
2IRMA Informatics & Radiation Physics for Medical and 
Technical Applications, Chrono-Environnement UMR CNRS 
6249, 25211 Montbéliard, France 
 
Purpose or Objective: To allow or not the patient transfer 
between 2 energy-matched Linacs, differing only by their 
MLC generation, in case of breakdown. 
 
Material and Methods: Two linacs were beforehand matched 
in terms of energy (TPR20,10) and each separate calculation 
model in the TPS validated. This retrospective comparison 
was performed with the calculated dose from the TPS to 
assess the impact of transferring a patient from one machine 
to another, for some fractions (n=1 to 5) over the whole 
treatment (N fractions). One should note that 3D plan 
verification failed in general if the measurements occurs on 
the wrong machine. 
Fifty VMAT plans were studied (head & neck , whole brain, 
rectum, prostate, other; 10 plans of each), corresponding to 
60 PTVs and 100 OARs. Dose was re-computed with the non-
planned machine, without any optimization, if up to n=5 
fractions are transferred. 
Reported dose-metrics (see ICRU-83) are Dmean (mean dose), 
Dmax (max dose), D95% and HI (homogeneity index) for all 
ROIs, and well-known parameters are used for some OARs, 
depending of OAR type (V20, V74,...). Each parameter is 
expressed as relative to the initial planned treatment. 
 
Results: There is a systematic over-dose delivering when 
transferring a patient from the “new generation” Linac 
(Mnew) to the “old” one (Mold). The opposite is checked. 
Dmean and Dmax variations are linearly dependent of the 
number of transferred fractions (R²=0.91), for PTVs and 
OARs. No linear correlation could be found for others 
metrics, which seem to strongly depend on each anatomy. 
Variations are always more important for OARs than for PTVs. 
The maximum difference was found as the Dmean on a right 
femur for a rectum treatment (11.4%). This value is increased 
to 15% and set as the maximum available for n=5. 
 
Conclusion: Dose differences are here mainly due to 
thickness variations of MLC leaves, over other design 
improvements (leaf profiles, rounded leaf ends,...), as dose 
variation is related to leaf thickness and OARs are on the 
other hand more affected by linac transfer than PTVs 
(protected ROIs are more often under leaves than targets). 
